Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring : Evidence for a spectrum of neonatal injury

Copyright: © 2024 Gupta et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited..

Biliary atresia is a neonatal disease characterized by damage, inflammation, and fibrosis of the liver and bile ducts and by abnormal bile metabolism. It likely results from a prenatal environmental exposure that spares the mother and affects the fetus. Our aim was to develop a model of fetal injury by exposing pregnant mice to low-dose biliatresone, a plant toxin implicated in biliary atresia in livestock, and then to determine whether there was a hepatobiliary phenotype in their pups. Pregnant mice were treated orally with 15 mg/kg/d biliatresone for 2 days. Histology of the liver and bile ducts, serum bile acids, and liver immune cells of pups from treated mothers were analyzed at P5 and P21. Pups had no evidence of histological liver or bile duct injury or fibrosis at either timepoint. In addition, growth was normal. However, serum levels of glycocholic acid were elevated at P5, suggesting altered bile metabolism, and the serum bile acid profile became increasingly abnormal through P21, with enhanced glycine conjugation of bile acids. There was also immune cell activation observed in the liver at P21. These results suggest that prenatal exposure to low doses of an environmental toxin can cause subclinical disease including liver inflammation and aberrant bile metabolism even in the absence of histological changes. This finding suggests a wide potential spectrum of disease after fetal biliary injury.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:19

Enthalten in:

PloS one - 19(2024), 4 vom: 01., Seite e0301824

Sprache:

Englisch

Beteiligte Personen:

Gupta, Kapish [VerfasserIn]
Xu, Jimmy P [VerfasserIn]
Diamond, Tamir [VerfasserIn]
de Jong, Iris E M [VerfasserIn]
Glass, Andrew [VerfasserIn]
Llewellyn, Jessica [VerfasserIn]
Theise, Neil D [VerfasserIn]
Waisbourd-Zinman, Orith [VerfasserIn]
Winkler, Jeffrey D [VerfasserIn]
Behrens, Edward M [VerfasserIn]
Mesaros, Clementina [VerfasserIn]
Wells, Rebecca G [VerfasserIn]

Links:

Volltext

Themen:

Benzodioxoles
Bile Acids and Salts
Biliatresone
Journal Article

Anmerkungen:

Date Completed 08.04.2024

Date Revised 08.04.2024

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0301824

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370681541